Linita

Linagliptin INN
DPP-4 inhibitor (Oral Antidiabetic)

Indication:
LinitaTM is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus

Dosage & Administration:
The recommended dose of LinitaTM is one tablet once daily. No dosage adjustment is required in patients with type 2 diabetes having renal or hepatic impairment

Preparation:
Each box contains 20 tablets in blister pack



  • Products By Trade Name

  • Products By Generic

  • Products By Therapeutic Class

  • Herbal & Nutraceuticals

  • AgroVet & Pesticides